Sufentanil Citrate Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as VERTICAL PHARMS. It is marketed under 1 brand name, including DSUVIA. Available in 1 different strength, such as EQ 0.03MG BASE, and administered through 1 route including TABLET;SUBLINGUAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"104361","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US9744129B2","cleaned_patent_number":"9744129","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2017-08-29","legal_status":"Granted"} US9744129B2 Formulation 29 Aug, 2017 Granted 05 Jan, 2027
{"application_id":"104363","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US10342762B2","cleaned_patent_number":"10342762","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2019-07-09","legal_status":"Granted"} US10342762B2 Formulation 09 Jul, 2019 Granted 05 Jan, 2027
{"application_id":"104364","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US10507180B2","cleaned_patent_number":"10507180","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2019-12-17","legal_status":"Patented case"} US10507180B2 Formulation 17 Dec, 2019 Patented case 05 Jan, 2027
{"application_id":"104347","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8252328B2","cleaned_patent_number":"8252328","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2012-08-28","legal_status":"Granted"} US8252328B2 Formulation 28 Aug, 2012 Granted 05 Jan, 2027
{"application_id":"104348","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8252329B2","cleaned_patent_number":"8252329","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2012-08-28","legal_status":"Patented case"} US8252329B2 Formulation 28 Aug, 2012 Patented case 05 Jan, 2027
{"application_id":"104351","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8535714B2","cleaned_patent_number":"8535714","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2013-09-17","legal_status":"Patented case"} US8535714B2 Formulation 17 Sep, 2013 Patented case 05 Jan, 2027
{"application_id":"104287","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8778393B2","cleaned_patent_number":"8778393","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2014-07-15","legal_status":"Patented case"} US8778393B2 15 Jul, 2014 Patented case 05 Jan, 2027
{"application_id":"104353","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8778394B2","cleaned_patent_number":"8778394","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2014-07-15","legal_status":"Patented case"} US8778394B2 15 Jul, 2014 Patented case 05 Jan, 2027
{"application_id":"104354","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8865211B2","cleaned_patent_number":"8865211","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2014-10-21","legal_status":"Patented case"} US8865211B2 21 Oct, 2014 Patented case 05 Jan, 2027
{"application_id":"104359","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US9320710B2","cleaned_patent_number":"9320710","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2016-04-26","legal_status":"Patented case"} US9320710B2 26 Apr, 2016 Patented case 05 Jan, 2027
{"application_id":"104362","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US10245228B2","cleaned_patent_number":"10245228","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2019-04-02","legal_status":"Patented case"} US10245228B2 Formulation 02 Apr, 2019 Patented case 05 Jan, 2027
{"application_id":"104345","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8226978B2","cleaned_patent_number":"8226978","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2012-07-24","legal_status":"Patented case"} US8226978B2 Formulation 24 Jul, 2012 Patented case 05 Jan, 2027
{"application_id":"104346","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8231900B2","cleaned_patent_number":"8231900","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-05","publication_date":"2012-07-31","legal_status":"Patented case"} US8231900B2 Formulation 31 Jul, 2012 Patented case 05 Jan, 2027
{"application_id":"104380","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"bd137df7ff6d47c5aa02","publication_number":"US10896751B2","cleaned_patent_number":"10896751","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-16","publication_date":"2021-01-19","legal_status":"Granted"} US10896751B2 Formulation 19 Jan, 2021 Granted 16 Mar, 2030
{"application_id":"104383","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"bd137df7ff6d47c5aa02","publication_number":"US11676691B2","cleaned_patent_number":"11676691","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-16","publication_date":"2023-06-13","legal_status":"Granted"} US11676691B2 Formulation 13 Jun, 2023 Granted 16 Mar, 2030
{"application_id":"116981","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"bd137df7ff6d47c5aa02","publication_number":"US12033733B2","cleaned_patent_number":"12033733","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-16","publication_date":"2024-07-09","legal_status":"Granted"} US12033733B2 Formulation 09 Jul, 2024 Granted 16 Mar, 2030
{"application_id":"104378","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"bd137df7ff6d47c5aa02","publication_number":"US8574189B2","cleaned_patent_number":"8574189","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-16","publication_date":"2013-11-05","legal_status":"Granted"} US8574189B2 Formulation 05 Nov, 2013 Granted 16 Mar, 2030
{"application_id":"104344","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8202535B2","cleaned_patent_number":"8202535","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-22","publication_date":"2012-06-19","legal_status":"Patented case"} US8202535B2 19 Jun, 2012 Patented case 22 Oct, 2030
{"application_id":"104355","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"71a01a18963d46259e8b","publication_number":"US8865743B2","cleaned_patent_number":"8865743","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-22","publication_date":"2014-10-21","legal_status":"Patented case"} US8865743B2 21 Oct, 2014 Patented case 22 Oct, 2030
{"application_id":"104386","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"a23eeca2ca6744bfbe0f","publication_number":"US8945592B2","cleaned_patent_number":"8945592","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-07-29","publication_date":"2015-02-03","legal_status":"Granted"} US8945592B2 Formulation 03 Feb, 2015 Granted 29 Jul, 2031
{"application_id":"116965","ingredient":"SUFENTANIL CITRATE","trade_name":"DSUVIA","family_id":"14886ee2783c4013a3a0","publication_number":"US11672738B2","cleaned_patent_number":"11672738","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-02","publication_date":"2023-06-13","legal_status":"Granted"} US11672738B2 Formulation 13 Jun, 2023 Granted 02 Feb, 2038

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Sufentanil Citrate

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.